| View |
|
DRP-10961-05
|
Ceftriaxone (as sodium)
|
Santezon
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Third-generation Cephalosporin)
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
28 March 2024
|
22 December 2026
|
| View |
|
DRP-10962-03
|
Etoricoxib
|
Etorigo-120
|
120 mg
|
Film-Coated Tablet
|
Non-steroidal Anti-inflammatory Drug (Selective COX-2 Inhibitor)
|
ACME Formulation Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
23 December 2026
|
| View |
|
DRP-10963-04
|
Etoricoxib
|
Etorigo-90
|
90 mg
|
Film-Coated Tablet
|
Non-steroidal Anti-inflammatory Drug (Selective COX-2 Inhibitor)
|
ACME Formulation Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 March 2024
|
23 December 2026
|
| View |
|
DRP-11022-01
|
Omeprazole (as sodium)
|
Viprazole
|
40 mg
|
Lyophilized Powder for Injection (IV Infusion)
|
Proton Pump Inhibitor (PPI)
|
Mason Pharma
|
India
|
CLIDP Conversion
|
17 March 2024
|
29 April 2027
|
| View |
|
DRP-11044-07
|
Potassium Citrate
|
Alkasure
|
1080 mg
|
Extended-Release Tablet
|
Antiurolithic
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
17 March 2024
|
18 January 2027
|
| View |
|
DRP-11228-01
|
Paracetamol
|
Kidiron-120
|
120 mg/ 5 mL
|
Suspension (Orange Flavor)
|
Antipyretic/Analgesic
|
Lloyd Laboratories, Inc.
|
Philippines
|
c
|
25 March 2024
|
15 February 2027
|
| View |
|
DRP-11424-04
|
Telmisartan + Amlodipine (as besilate)
|
None
|
80 mg/5 mg
|
Tablet
|
Angiotensin II Antagonist/ Calcium Channel Blocker
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
17 March 2024
|
10 March 2027
|
| View |
|
DRP-11492-05
|
Omeprazole (as sodium)
|
Kinmeprazole
|
40 mg
|
Lyophilized Powder for Injection (IV Infusion)
|
Proton Pump Inhibitor (PPI)
|
Jodas Expoim Pvt. Ltd
|
India
|
CLIDP Conversion
|
20 March 2024
|
17 March 2027
|
| View |
|
DRP-11635-02
|
Amlodipine (as besilate)
|
Gopres-5
|
5 mg
|
Tablet
|
Calcium Channel Blocker
|
Ratnatris Pharmaceuticals Private Limited
|
India
|
CLIDP Conversion
|
29 March 2024
|
04 April 2027
|
| View |
|
DRP-11706-01
|
Paracetamol
|
Kidiron-100
|
100 mg/ mL
|
Suspension (Oral Drops)
|
Analgesic/Antipyretic
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
25 March 2024
|
19 April 2027
|
| View |
|
DRP-11789-06
|
Dapagliflozin
|
Azfloz
|
10 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug (SGLT2 Inhibitor)
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
21 March 2024
|
29 April 2027
|
| View |
|
DRP-11801-06
|
Cefuroxime (as sodium)
|
Venirex
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
29 March 2024
|
29 April 2027
|
| View |
|
DRP-11805-06
|
Co - Amoxiclav
|
Bacticox 625
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin + Beta-Lactamase Inhibitor)
|
Yeluri Formulations Pvt Ltd
|
India
|
CLIDP Conversion
|
04 April 2024
|
05 May 2027
|
| View |
|
DRP-11813-04
|
Telmisartan + Amlodipine (as besilate)
|
Team Duo
|
40 mg / 5 mg
|
Tablet
|
Angiotensin II Antagonist/Calcium Channel Blocker
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
20 March 2024
|
02 May 2027
|
| View |
|
DRP-11813-05
|
Telmisartan + Amlodipine (as besilate)
|
None
|
40 mg/5 mg
|
Tablet
|
Angiotensin II Antagonist/Calcium Channel Blocker
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
24 March 2024
|
02 May 2027
|
| View |
|
DRP-11847-07
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Unomet
|
50 mg/ 1 g
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
24 March 2024
|
10 May 2027
|
| View |
|
DRP-11848-08
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Unomet
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
17 March 2024
|
10 May 2027
|
| View |
|
DRP-11879-01
|
Atorvastatin (as calcium)
|
None
|
40 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
25 March 2024
|
18 May 2027
|
| View |
|
DRP-11925-01
|
Candesartan Cilexetil
|
None
|
8 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 March 2024
|
20 May 2027
|
| View |
|
DRP-12080-05
|
Nebivolol (as hydrochloride)
|
None
|
5 mg
|
Tablet
|
Beta Bocking Agent
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 March 2024
|
09 June 2027
|